Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07347665
NA

Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the M2 Segment of Middle Cerebral Artery

Sponsor: Hyogo Medical University

View on ClinicalTrials.gov

Summary

RESCUE-M2O trial is a prospective, open label, blinded endpoint (PROBE), two-arm, randomized, controlled, post-market study to assess the efficacy and safety of endovascular therapy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery.

Official title: Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the M2 Segment of Middle Cerebral Artery (the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism-M2 Occlusion Trial: RESCUE-M2O Trial)

Key Details

Gender

All

Age Range

18 Years - 84 Years

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2025-12-01

Completion Date

2030-03-31

Last Updated

2026-02-24

Healthy Volunteers

No

Interventions

PROCEDURE

Endovascular therapy

Endovascular therapy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery.

Locations (2)

Hyogo Medical University

Nishinomiya, Hyōgo, Japan

Hyogo Medical University

Nishinomiya, Hyōgo, Japan